Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD4 Cell Counts”

158 trials

Showing 20 of 158 results

Not applicableStudy completedNCT00120510
What this trial is testing

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 816
Testing effectiveness (Phase 2)Study completedNCT00316589
What this trial is testing

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Who this might be right for
HIV Infections
Bavarian Nordic 581
Not applicableStudy completedNCT00002032
What this trial is testing

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pharmacia 750
Testing effectiveness (Phase 2)UnknownNCT00002451
What this trial is testing

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 8
Large-scale testing (Phase 3)Study completedNCT00002389
What this trial is testing

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Early research (Phase 1)Study completedNCT00002196
What this trial is testing

CI-1012 in HIV-Infected Patients

Who this might be right for
HIV Infections
Parke-Davis 32
Testing effectiveness (Phase 2)Study completedNCT00113282
What this trial is testing

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 57
Post-approval studies (Phase 4)UnknownNCT01235013
What this trial is testing

Effect of Maraviroc (MCV) on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cells/mm3

Who this might be right for
HIV-1 Infection
Hospital Clinic of Barcelona 60
Not applicableUnknownNCT04515225
What this trial is testing

COVID-19 Prevalence in HIV-infected Patients

Who this might be right for
HIV Infections
University Hospital, Strasbourg, France 500
Testing effectiveness (Phase 2)Study completedNCT00000889
What this trial is testing

Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Early research (Phase 1)UnknownNCT00005120
What this trial is testing

The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Sarawak MediChem Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00002106
What this trial is testing

A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3

Who this might be right for
HIV Infections
Glaxo Wellcome 104
Testing effectiveness (Phase 2)Study completedNCT00000909
What this trial is testing

Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT00001122
What this trial is testing

An Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 74
Not applicableStudy completedNCT00001611
What this trial is testing

Immune Activity Against CVM Retinitis

Who this might be right for
Acquired Immunodeficiency SyndromeCytomegalovirus RetinitisHIV Infection
National Eye Institute (NEI) 15
Not applicableStudy completedNCT00000900
What this trial is testing

The Effects of Illnesses on HIV Levels in the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Testing effectiveness (Phase 2)Study completedNCT00120185
What this trial is testing

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 130
Large-scale testing (Phase 3)Study completedNCT01348308
What this trial is testing

Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients

Who this might be right for
HIV-1 InfectionAIDS
ANRS, Emerging Infectious Diseases 407
Testing effectiveness (Phase 2)Study completedNCT00110812
What this trial is testing

Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 267
Testing effectiveness (Phase 2)Study completedNCT03568812
What this trial is testing

The Role of Probiotics in HIV Patients With Immunological Non-Responder

Who this might be right for
HIV InfectionsImmunological Abnormality
Indonesia University 80
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation